ArriVent BioPharma Inc. C...

18.14
0.24 (1.34%)
At close: Apr 17, 2025, 3:59 PM
18.13
-0.05%
Pre-market: Apr 21, 2025, 06:54 AM EDT

ArriVent BioPharma Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
74.29M 150.39M 163.37M 37.28M
144.57M n/a n/a n/a
47.68M n/a n/a 2K
126K 2.84M 72K 87K
500K 761K 500K 250K
n/a -240K n/a n/a
n/a 8.69M n/a n/a
226.98M 159.97M 182.62M 42.95M
154K 291K 139K n/a
n/a n/a n/a n/a
47.96M 3.13M 211K 89K
274.94M 163.1M 182.83M 43.04M
3.78M 4.53M 3.09M 293K
n/a n/a -1 n/a
n/a n/a n/a n/a
4.16M 3.35M 2.46M n/a
17.27M 11.62M 8.36M 1.82M
n/a n/a n/a n/a
n/a n/a n/a n/a
14K 177K 11K n/a
17.29M 11.8M 8.37M 1.82M
176K 317K 139K n/a
3K n/a 4K 4K
-238.33M -157.84M -88.51M -51.61M
-211K n/a -4K -4K
257.65M 151.3M 174.46M 41.22M
192.25M n/a n/a 2K